Upper Face Botulinum Toxin in Male Patients

Treatment Sequencing, Anatomy and Safety Considerations

The aesthetic outcome a male patient wants from upper face botulinum toxin is meaningfully different from the outcome the average female patient wants, with most men preferring a relatively straight eyebrow that tapers off naturally and very much not wanting the lifted arch shape that defines a more feminine brow position. This difference matters from the moment treatment planning begins, because the entire forehead injection pattern needs to be calibrated to preserve the natural shape and avoid producing lift, and getting that decision wrong at the planning stage produces a result that feminises the patient’s appearance regardless of how technically clean the individual injections were.

The starting position for every upper face treatment is the consultation question about whether the patient wants any lift at all, because some men do want a subtle elevation and others want the existing brow shape stabilised without any change in position. Once that question is answered, the treatment plan flows logically from anatomy, with the glabella treated first because it is the easiest and most predictable region, followed by the forehead where the safety margin and the brow shape protection both need careful thought, and finishing at the crow’s feet where the dose gradient maintains natural cheek mobility.

Why the glabella is the right starting point

The glabella is the easiest region to treat first because the muscles involved are relatively isolated, with the corrugator supercilii and procerus having clear insertion points that can be identified through patient expression. Asking the patient to frown produces small boomerang-shaped lines that mark the insertion point of the corrugator, and the position of those lines tells you exactly where the muscle is most active and where the bulk of the dose needs to land.

The corrugator sits lateral to the midpupillary line in most patients, with frontalis taking over medially, which gives you a natural boundary to inject within and reduces the risk of unintended frontalis treatment medial to the brow. The first injection lands at the bulk of the corrugator, with a second separated injection placed slightly more laterally to catch the fibres that extend along the muscle’s path, and this separation is preferable to a single bolus because it covers the full active length of the muscle without relying on diffusion alone to reach the lateral fibres.

Procerus and dose adjustment based on muscle strength

The procerus typically produces the horizontal line that appears across the nose when patients wrinkle the upper face, and the dose needs to be calibrated to how strong this muscle actually is in the individual patient. A patient with strong corrugators and a weak procerus does not need a high dose at the procerus point, which leaves additional units available for redistribution to areas where the muscle activity is greater. The visible wrinkle pattern across the nose during expression is the practical cue for how active the procerus actually is, with a horizontal nasal line being the diagnostic sign that the muscle warrants a higher dose.

This kind of dose redistribution is one of the practical advantages of treating an isolated region like the glabella first, because the unit budget for the whole upper face can be allocated according to muscle strength across the individual patient’s anatomy without being forced into a standard pattern that may not match what is in front of you.

Treating the male forehead without creating an arch

The forehead injection pattern in male patients is built around preserving the existing brow shape, with the safety margin from the orbital rim acting as the anatomical anchor that keeps the result stable. A 2cm margin above the orbital rim is the working distance, with the curve of the rim followed naturally so that the lower edge of the treated area sits parallel to the brow line. Injecting closer to the rim than this produces a sensation of heaviness because the lower frontalis fibres are no longer counterbalancing the depressor muscles around the eye.

The injection pattern divides the forehead in half along the vertical midline, with one injection placed slightly to either side of the midline and not directly on it, because the aponeurosis along the very centre of the forehead contains relatively little muscle and a midline injection wastes a unit on tissue that is not contributing to movement. Four injection points spread evenly across the line of treatment captures the strong frontalis activity across the forehead, with patient feedback during the planning frown helping to identify any patches of stronger muscle that need additional coverage.

The two-line approach and the patch you almost miss

A common error in male forehead treatment is leaving an untreated patch of muscle higher up on the forehead, which produces a frustrating presentation two weeks later where the patient returns with a small area still moving while everything around it is relaxed. The way to avoid this is to look carefully during the planning frown for muscle activity above the main line of treatment, because previous botox can mask the underlying activity pattern and create the impression that the upper forehead is quiet when it actually contains active muscle fibres.

Adding a second line of treatment higher up addresses this risk, with a higher dose used lower on the forehead where the muscle is denser and a lower dose used higher up where the activity is lighter. This dose gradient preserves enough medial brow support to prevent the brow from dropping, while still allowing a small amount of brow movement from the untreated lateral frontalis, which is what produces a natural-looking result and avoids the frozen forehead presentation.

Crow’s feet and the dose gradient from tail to cheek

Orbicularis oculi is stronger superiorly than inferiorly, which means the highest dose in the crow’s feet pattern lands at the tail of the eyebrow where the muscle is strongest, with an intermediate dose below that, and the lowest dose furthest down towards the cheek. This gradient maintains cheek mobility for natural smiling, which is the outcome most patients actually want even if they cannot articulate it before treatment, and it prevents the flat midface presentation that comes from over-treating the lower orbicularis.

Asking the patient to look away from the needle is a practical comfort technique that also opens up the injection field, with the patient turning their gaze in the opposite direction so the injector can approach the lateral canthus area without the eye in the line of sight. The injection at this point is superficial because anything deeper begins to approach the lacrimal gland and the lateral rectus muscle, with a working distance of 1.5cm separating the injection plane from those deeper structures.

Safety techniques across the upper face

The single most useful safety technique in the glabella is finger pressure over the orbital rim during injection, which presses directly over the supratrochlear and supraorbital foramina and prevents toxin from tracking through these openings into the orbit. The orbital membrane is the boundary that protects the deeper structures of the eye, and pressure during injection significantly reduces the chance of diffusion through this membrane.

The angle of entry also affects diffusion risk, with a parallel-to-muscle approach being lower risk than an angled approach for an injector still building experience with the region. Aiming parallel to the corrugator means the bolus deposits along the natural plane of the muscle, which keeps the toxin within the intended compartment and reduces the chance of unwanted spread to adjacent structures. The depth gradient across the corrugator injection points follows the natural anatomy of the muscle as it travels across the brow, with the medial bulk treated deepest and the lateral fibres reached with progressively more superficial injections.

A small practical detail that prevents an avoidable complication is to inject just adjacent to the marker dot rather than through it, because needle passage through ink can tattoo the skin and leave a permanent mark that no patient will be pleased about, which is a particular issue at the glabella where the skin sits forward on the face and any mark is highly visible.

Why the crow’s feet are the technically easiest region

The crow’s feet are the technically simplest region of the upper face because the anatomy is genuinely sparse compared to the glabella or the forehead. The layers from surface to bone are the dermis, a thin hypodermis, the fascia, the orbicularis oculi muscle, and the reticular tissue overlying the bone, with no major arteries or nerves crossing the injection field at the depth used for crow’s feet treatment. The technical demands here are lower and the dose decisions more straightforward than in the glabella, where proximity to the orbital foramina makes precise pressure technique essential to safe practice.

Want to overcome your fear of complications, confidently master anatomy and 10x your injection skills? Join us for one of Dr Tim’s FREE upcoming webinars. 

Ready to master deep fat pad anatomy and transform your consultation approach?

Join Dr. Tim's upcoming webinar where you'll explore the specific locations and volumes of deep fat compartments, understand when to inject deep versus superficial layers, and develop the anatomical communication skills that build patient trust and improve treatment outcomes.

Register for the Free Webinar →

Learn to see facial anatomy the way expert injectors do, enabling treatment plans based on structural understanding rather than surface-level symptom chasing.

Anatomy Webinar